Denemek ALTIN - Özgür
Blood Test For Detecting Cancer
DataQuest
|November 2019
53% of companies openly admit that limited IT resources are significantly slowing down their digital transformation efforts. Here is how an organization tackles this issue
The final and inconclusive proof of the disease is tissue biopsy, a relatively painful process. In certain cases, the tumour is not accessible or the patient is very weak for biopsy. How then do the can oncologists confirm the presence of cancer?
Cancer is a dreaded term in most families. Across the globe, annually about 8 million people die of cancer. In USA alone, every year about 40,000 women die of breast cancer. Mammograms are the best test, yet they often produce false positives, which can warrant unwanted biopsies and surgeries. So called, “high-risk” lesions have abnormal cells and patients are advised surgery. About 90% of the time, the lesion is benign and surgery is an expensive and painful wasted exercise. The final and inconclusive proof of the disease is tissue biopsy, a relatively painful process. In certain cases, the tumour is not accessible or the patient is very weak for biopsy. How then do can oncologists confirm the presence of cancer?
The Research
The research related to cancer is predominantly on two major fronts – 1) to find drugs and ways to treat cancer and 2) to detect cancer at a very early stage where the chances of recovery and remission are high. Typically, people suspect cancer as the cause only when it manifests in some obvious and visible form. Nevertheless, often by then, the disease has progressed to an advanced stage – a stage beyond treatment. Can doctors detect them very early even before the person feels any symptoms? By detecting early, doctors can treat and save many lives and spare many people of anxiety and agony.
Can a simple blood test predict, detect and confirm the presence of cancer? yes, for a few types of cancers it is possible. Colorectal Cancer (CRC) is one for which a blood test is available. Testing the blood for the presence of tumour cells and DNA is a non-invasive approach compared to the invasive biopsy, which is a surgery.
Bu hikaye DataQuest dergisinin November 2019 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
DataQuest'den DAHA FAZLA HİKAYE
DataQuest
The GCC Boom: India's Journey from Cost Arbitrage to Innovation
India's 1,700+ GCCs are shifting from cost to co-creation. Can India convert scale, AI depth, and leadership ambition into true orchestration power for global enterprises?
16 mins
October 2025
DataQuest
'Je ne sais quoi' is now 'Je ne sais quAl': From metrics to experiences at Genesys Xperience 2025
At Genesys Xperience 2025, CEO Tony Bates showed how agentic AI is shifting businesses from metrics to empathy-driven experiences that build trust.
8 mins
October 2025
DataQuest
Legacy is not enough: Why enterprises need Al-native SaaS
Phenom's Kiran Menon shares how AI-first SaaS is redefining talent experience, augmenting legacy systems, and delivering measurable outcomes.
4 mins
October 2025
DataQuest
SAP's Jan Bungert on how business Al and data cloud are powering India's Techade
Jan Bungert, CRO of SAP Business AI, discusses how SAP is embedding AI into core applications and leveraging SAP Business Data Cloud to help Indian enterprises like Parle and Mahindra unlock trusted insights, efficiency, and measurable outcomes.
4 mins
October 2025
DataQuest
Why the operating system is no longer just plumbing: Raj Das on the future of RHEL
Many enterprises still think of the operating system as a background utility-something you set up once and forget. In reality, modern OS platforms like RHEL are dynamic, intelligent enablers of innovation.
5 mins
October 2025
DataQuest
Don't bolt Al onto ERP—build a connected system from day one
In an exclusive interaction with Dataquest, Paritosh Ladhani, Joint Managing Director of SLMG Beverages, outlines how the Coca-Cola bottler has moved from legacy processes to a fully digitised, AI-enabled, smart-factory ecosystem.
10 mins
October 2025
DataQuest
The future isn't about isolated robots
C Balaji, PSG Head, TVS Electronics draws a rough, but realistic, picture of factories that embrace robots for new business models as well as faster (and smarter) assembly lines and packaging. It's an age of managed automation, performance-based services, flexible manufacturing, mass customisation, vision-intelligence, serialisation and traceability across all areas. But would this world be with or without taxes, accidents and retrofitting? Let's take a walk with Balaji around what's changing and what's staying.
4 mins
October 2025
DataQuest
Hitting 'Reset', Risking 'Reboot' - VMware's Bold Leap from Complexity to Clarity
VMware, under Broadcom, is redefining cloud with VCF 9.0-simplifying portfolios, reshaping partner strategy, and positioning as a product-led platform.
4 mins
October 2025
DataQuest
Feeding the Al beast, with some beauty
Jameson Mendonca, Power Generation Business Leader, Cummins Power System opens up some pistons of carbon hunger of modern data centres while he also shows how Natural gas, Hydrotreated Vegetable Oil, Life Cycle Assessments (LCAs) and Environmental Product Declarations (EPDs) can weld well in this new era. And why we should we worried about scope 1 and 2 in the race to be no.1 in AI.
6 mins
October 2025
DataQuest
We allow you to say No!
What's ETA status of real consent, useful personalisation, technology for the everyday commuter and data ethics in the super-busy travel terminal? Anytime now or are we still catching this bus?
4 mins
October 2025
Translate
Change font size
